Glipizide 10 milligrams. Glipizide sensitizes the beta cells of pancreatic islets of Langerhans insulin response, meaning that more insulin is released in response to glucose than would be without glipizide ingestion. Glipizide acts by partially blocking potassium channels among beta cells of pancreatic islets of Langerhans. By blocking potassium channels, the cell depolarizes, which results in the opening of voltage-gated calcium channels. The resulting calcium influx encourages insulin release from beta cells. Glipizide Glipizide is an oral rapid- and short-acting anti-diabetic medication from the sulfonylurea class. It is classified as a second-generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation
Ryan Langerhans between the Double-A Greenville Braves and the Triple-A Richmond Braves. Langerhans was called up by the Braves in September. On September 5, in his second game of the season, Langerhans got his first major league hit coming against the Pittsburgh Pirates. Despite making his major league debut in 2002, Langerhans did not become an everyday big-league player until 2005, getting playing time for the Braves in all three outfield positions. He is part of the group of 18 rookie players nicknamed the "Baby Braves" that Atlanta called up from its minor league system during the 2005 season. Langerhans started 2006